Table 1.
Baseline characteristics of clinical trial participants (N = 18).
| Characteristics | Number of patients (range of %) |
|---|---|
| Median age, years (range) | 46.2 (21–68) |
| Sex | |
| Female | 8 (44.4) |
| Male | 10 (56.6) |
| Race | |
| Caucasian | 10 (55.6) |
| Hispanic | 4 (22.2) |
| African American | 2 (11.1) |
| Asian | 2 (11.1) |
| Sarcoma subtype | |
| Malignant peripheral nerve sheath tumors | 6 (33.3) |
| Pigmented villonodular synovitis | 3 (16.7) |
| Pleiomorphic sarcoma | 2 (11.1) |
| Leiomyosarcoma | 2 (11.1) |
| Gastrointestinal stromal tumor | 2 (11.1) |
| Spindle cell sarcoma | 1 (5.6) |
| Epithelioid angiomyolipoma | 1 (5.6) |
| Hemangiopericytoma | 1 (5.6) |
| Number of prior therapies | |
| 0–1 | 7 (38.9) |
| >2 | 11 (61.1) |